Cargando…

EMT, CTCs and CSCs in tumor relapse and drug-resistance

Tumor relapse and metastasis are the primary causes of poor survival rates in patients with advanced cancer despite successful resection or chemotherapeutic treatment. A primary cause of relapse and metastasis is the persistence of cancer stem cells (CSCs), which are highly resistant to chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitra, Abhisek, Mishra, Lopa, Li, Shulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484413/ https://www.ncbi.nlm.nih.gov/pubmed/25986923

Ejemplares similares

MiRNA-mediated EMT and CSCs in cancer chemoresistance
por: Dong, Bing, et al.
Publicado: (2021)

Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments
por: Aramini, Beatrice, et al.
Publicado: (2022)

Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients
por: SHIMADA, RYU, et al.
Publicado: (2012)

Cancer stem cells (CSCs), cervical CSCs and targeted therapies
por: Huang, Ruixia, et al.
Publicado: (2016)

ABC transporters in CSCs membranes as a novel target for treating tumor relapse
por: Zinzi, Laura, et al.
Publicado: (2014)

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014)

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
por: Phi, Lan Thi Hanh, et al.
Publicado: (2018)

Resistance to drugs and cell death in cancer stem cells (CSCs)
por: Safa, Ahmad R
Publicado: (2020)

Pancreatic CSCs and microenvironment
por: Ilmer, Matthias, et al.
Publicado: (2015)

CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
por: Sulaiman, Andrew, et al.
Publicado: (2019)

Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS)
por: Leng, Xiaoling, et al.
Publicado: (2021)

ATLAS computing on CSCS HPC
por: Filipcic, Andrej, et al.
Publicado: (2015)

ATLAS computing on CSCS HPC
por: Hostettler, Michael Artur, et al.
Publicado: (2015)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
por: Xu, Ying, et al.
Publicado: (2023)

Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2023)

Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)
por: Mathias, Trevor J., et al.
Publicado: (2020)

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
por: Mamdouhi, Tania, et al.
Publicado: (2019)

Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact
por: Vardas, Vasileios, et al.
Publicado: (2023)

Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications
por: Li, Dai, et al.
Publicado: (2023)

Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
por: Zhang, Yanlong, et al.
Publicado: (2023)

Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate
por: Papadaki, Maria A., et al.
Publicado: (2022)

CSCs: regenerating optimism for osteosarcoma treatment
por: Levin, Adam S.
Publicado: (2018)

ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017)

Eradication of CSCs: the roadmap for curing cancer
por: Romano, Simona, et al.
Publicado: (2020)

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
por: Allen, Joshua E., et al.
Publicado: (2013)

Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
por: Hurtado, Pablo, et al.
Publicado: (2020)

Biosensors for the Isolation and Detection of Circulating Tumor Cells (CTCs) in Point-of-Care Settings
por: Goldstein, Isaac, et al.
Publicado: (2023)

Correlation between cancer stem cells (CSCs) and tumor-infiltrating lymphocytes (TILs): do TILs interact with CSCs in non-small cell lung cancer?
por: Ling, Min, et al.
Publicado: (2020)

ERBB signaling in CTCs of ovarian cancer and glioblastoma
por: Geethadevi, Anjali, et al.
Publicado: (2017)

CTCs 2020: Great Expectations or Unreasonable Dreams
por: Rossi, Elisabetta, et al.
Publicado: (2019)

Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
por: De Francesco, Ernestina M., et al.
Publicado: (2018)

Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
por: Renz, Bernhard W., et al.
Publicado: (2017)

Functional interplay between long non-coding RNAs and Breast CSCs
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2022)

CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)
por: Tayoun, Tala, et al.
Publicado: (2019)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

Phenotype-related drug sensitivity analysis of single CTCs for medicine evaluation
por: Pei, Haimeng, et al.
Publicado: (2020)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018)

Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy
por: Liao, Wenhao, et al.
Publicado: (2022)

Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas
por: Dao, Long, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bt3hga3fbj9mbbfrhlcjr3pumj